Our previous studies have shown that human native low density lipoprotein (LDL) can be oxidized by activated human monocytes. In this process, both activation of protein kinase C (PKC) and induction of superoxide anion (O 2 . ) production are required. PKC is a family of . by superoxide dismutase prevented LDL oxidation (2, 3). General antioxidants such as butylated hydroxytoluene, vitamin E, and ascorbate also inhibited monocyte-mediated oxidation of LDL (2, 4, 5). We also found that increases in intracellular Ca 2ϩ levels, cytosolic phospholipase A 2 activity, and protein kinase C (PKC) activity were required for monocyte-mediated LDL lipid oxidation (6 -8). We routinely measure monocyte-mediated LDL oxidation at 24 h after monocyte activation, a time when considerable oxidation products have accumulated and the oxidation begins to plateau. In our earlier studies, PKC activity was shown to contribute to LDL lipid oxidation both early and late during the 24-h incubation period (7).To date at least 12 isoenzymes of PKC having differential activator responsiveness, cellular distribution, and substrate specificity have been reported in mammalian tissue. They are divided into three major groups: conventional PKCs (␣, I, II, and ␥), novel PKCs (␦, ⑀, , and ), and atypical PKCs (, , , and ) (reviewed in Ref. 9). Although only cPKCs are Ca 2ϩ -dependent, all three groups of PKCs are believed to participate in signal transduction (9, 10), and accumulating evidence suggests that PKC isoenzymes likely play unique roles and induce different functional changes within cells.In previous studies, we found that a Ca 2ϩ -dependent cPKC was involved in the process of O 2 . production and required for LDL lipid oxidation by activated monocytes (7), we therefore initiated studies to identify which cPKC isoenzyme(s) was involved in these processes. In the present studies, PKC isoenzyme-specific antisense oligonucleotides (ODN) were carefully designed and then used to suppress the expression of individual isoenzymes. After establishing efficacy and selectivity of antisense inhibition by Western analysis, the ODN were then tested for their effects on monocyte-mediated O 2 . production and LDL lipid oxidation. Our data demonstrate that PKC␣, but not PKCI or PKCII, regulates monocyte O 2 . production as well as monocyte-mediated LDL lipid oxidation.